Randomized, Open-Label Phase II Study Comparing Capecitabine- Cisplatin Every 3 Weeks with S-1-Cisplatin Every 5 Weeks in Chemotherapy-Naïve Patients with HER2-Negative Advanced Gastric Cancer: OGSG1105, HERBIS-4A Trial

HISATO KAWAKAMI,ATSUSHI TAKENO,SHUNJI ENDO,YOICHI MAKARI,JUNJI KAWADA,HIROKAZU TANIGUCHI,SHIGEYUKI TAMURA,NAOTOSHI SUGIMOTO,YUTAKA KIMURA, TAKAO TAMURA,KAZUMASA FUJITANI,DAISUKE SAKAI,TOSHIO SHIMOKAWA,YUKINORI KUROKAWA,TAROH SATOH

The Oncologist 2018;23:1–9